clindamycin and Herpes Zoster

clindamycin has been researched along with Herpes Zoster in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lovell, B	1

Other Studies

2 other study(ies) available for clindamycin and Herpes Zoster

Article	Year
Trigeminal herpes zoster: early recognition and treatment are crucial. BMJ case reports, 2015, Mar-20, Volume: 2015 Topics: Acyclovir; Antiviral Agents; Clindamycin; Drug Therapy, Combination; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Return to Work; Treatment Outcome; Trigeminal Nerve; Virus Activation	2015
Drugs for AIDS and associated infections. The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine	1995

Article

Year

Trigeminal herpes zoster: early recognition and treatment are crucial.

BMJ case reports, 2015, Mar-20, Volume: 2015

Topics: Acyclovir; Antiviral Agents; Clindamycin; Drug Therapy, Combination; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Return to Work; Treatment Outcome; Trigeminal Nerve; Virus Activation

2015

Drugs for AIDS and associated infections.

The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995